BiVictriX Therapeutics (BVX) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisChartInsider Trades BiVictriX Therapeutics (LON:BVX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage42.56%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)£1,400.00Number OfInsiders Selling(Last 12 Months)0 Get BVX Insider Trade Alerts Want to know when executives and insiders are buying or selling BiVictriX Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BVX Insider Buying and Selling by Quarter Ad InvestorPlaceWhat This Post-Election Shift Means for Your InvestmentsThe election may be over, but its impact on financial markets is only beginning. New trends are emerging, bringing both challenges and opportunities for investors. Many of these changes are flying under the radar, yet they have the potential to reshape the financial landscape for years to come. Understanding how these shifts could affect your wealth—and what steps to take—has never been more important.Click here now to watch the full briefing and prepare for what's next. BiVictriX Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/30/2024Robert Edward HawkinsInsiderBuy20,000GBX 7£1,400 (Data available from 1/1/2013 forward) BVX Insider Trading Activity - Frequently Asked Questions Who is on BiVictriX Therapeutics's Insider Roster? The list of insiders at BiVictriX Therapeutics includes Iain Gladstone Ross, Robert Edward Hawkins, and Tiffany Jane Thorn. Learn more on insiders at BVX. What percentage of BiVictriX Therapeutics stock is owned by insiders? 42.56% of BiVictriX Therapeutics stock is owned by insiders. Learn more on BVX's insider holdings. Which BiVictriX Therapeutics insiders have been buying company stock? The following insider purchased BVX shares in the last 24 months: Robert Edward Hawkins (£1,400). How much insider buying is happening at BiVictriX Therapeutics? Insiders have purchased a total of 20,000 BVX shares in the last 24 months for a total of £1,400 bought. BiVictriX Therapeutics Key ExecutivesMs. Tiffany Jane Thorn BSc. MSc. (Age 37)M.Sc., CEO & Executive Director Compensation: $192.5kDr. Adrian Howd Ph.D. (Age 53)Chief Business Officer & CFO Simon WallworkSecretary More Insider Trading Tools from MarketBeat Related Companies Sareum Insider Buying Oncimmune Insider Buying Roquefort Therapeutics Insider Buying Fusion Antibodies Insider Buying Oxford BioDynamics Insider Buying Destiny Pharma Insider Buying ReNeuron Group Insider Buying Oxford Cannabinoid Technologies Insider Buying Oxford Nanopore Technologies Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (LON:BVX) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our...Desko Digital | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BiVictriX Therapeutics Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share BiVictriX Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.